Christopher H. van Dyck
Azheimer's Disease Research Unit
Department of Psychiatry
Yale University School of Medicine
New Haven
USA
Name/email consistency: high
- Cognitive and psychiatric effects of vitamin B12 replacement in dementia with low serum B12 levels: a nursing home study. van Dyck, C.H., Lyness, J.M., Rohrbaugh, R.M., Siegal, A.P. Int. Psychogeriatr (2009)
- Striatal dopamine transporters correlate with simple reaction time in elderly subjects. van Dyck, C.H., Avery, R.A., MacAvoy, M.G., Marek, K.L., Quinlan, D.M., Baldwin, R.M., Seibyl, J.P., Innis, R.B., Arnsten, A.F. Neurobiol. Aging (2008)
- Imaging microglial activation in Alzheimer's disease: what does it mean?. van Dyck, C.H. Biol. Psychiatry (2008)
- A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease. van Dyck, C.H., Tariot, P.N., Meyers, B., Malca Resnick, E. Alzheimer. Dis. Assoc. Disord (2007)
- A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil. van Dyck, C.H., Schmitt, F.A., Olin, J.T. Am. J. Geriatr. Psychiatry (2006)
- Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. van Dyck, C.H., Malison, R.T., Jacobsen, L.K., Seibyl, J.P., Staley, J.K., Laruelle, M., Baldwin, R.M., Innis, R.B., Gelernter, J. J. Nucl. Med. (2005)
- Central serotonin transporter availability measured with [123I]beta-CIT SPECT in relation to serotonin transporter genotype. van Dyck, C.H., Malison, R.T., Staley, J.K., Jacobsen, L.K., Seibyl, J.P., Laruelle, M., Baldwin, R.M., Innis, R.B., Gelernter, J. Am. J. Psychiatry (2004)
- Understanding the latest advances in pharmacologic interventions for Alzheimer's disease. van Dyck, C.H. CNS. Spectr (2004)
- Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. van Dyck, C.H., Seibyl, J.P., Malison, R.T., Laruelle, M., Zoghbi, S.S., Baldwin, R.M., Innis, R.B. Am. J. Geriatr. Psychiatry (2002)
- Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder. van Dyck, C.H., Quinlan, D.M., Cretella, L.M., Staley, J.K., Malison, R.T., Baldwin, R.M., Seibyl, J.P., Innis, R.B. Am. J. Psychiatry (2002)
- Neuroimaging in Alzheimer's disease: relevance for treatment. van Dyck, C.H. Curr. Psychiatry. Rep (2001)
- Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group. van Dyck, C.H., Newhouse, P., Falk, W.E., Mattes, J.A. Arch. Gen. Psychiatry (2000)
- Age-related decline in central serotonin transporter availability with [(123)I]beta-CIT SPECT. van Dyck, C.H., Malison, R.T., Seibyl, J.P., Laruelle, M., Klumpp, H., Zoghbi, S.S., Baldwin, R.M., Innis, R.B. Neurobiol. Aging (2000)
- Equilibrium modeling of 5-HT(2A) receptors with [18F]deuteroaltanserin and PET: feasibility of a constant infusion paradigm. van Dyck, C.H., Soares, J.C., Tan, P.Z., Staley, J.K., Baldwin, R.M., Amici, L.A., Fu, X., Garg, P.K., Seibyl, J.P., Charney, D.S., Innis, R.B. Nucl. Med. Biol. (2000)
- Absence of an apolipoprotein E epsilon4 allele is associated with increased parietal regional cerebral blood flow asymmetry in Alzheimer disease. van Dyck, C.H., Gelernter, J., MacAvoy, M.G., Avery, R.A., Criden, M., Okereke, O., Varma, P., Seibyl, J.P., Hoffer, P.B. Arch. Neurol. (1998)
